Coexistence of reversible cerebral neurotoxicity and irreversible cerebellar atrophy following an intrathecal methotrexate chemotherapy: two case reports.
Masterson
K
K
Merlini
L
L
Lövblad
K O
KO
D000293:Adolescent; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001284:Atrophy; D001921:Brain / Q000187:drug effects / Q000473:pathology*; D002531:Cerebellum / Q000187:drug effects / Q000473:pathology; D002648:Child; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D015448:Leukemia, B-Cell / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*
D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate